Skip to content

Organon OGN Net debt / EBITDA

Net debt / EBITDA at other companies

Pfizer logo
PfizerPFE
3.8×
Amgen logo
AmgenAMGN
3.7×-0.7×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
3.3×+1.1×
Biogen logo
BiogenBIIB
1.2×+0.3×
AbbVie logo
AbbVieABBV
2.5×
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
1.8×

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%
Enterprise value$10.98B-26.4%
P/E6.6×+2.1×
P/S0.6×-0.8×

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Calculated from Organon’s reported figures.

Based on the most recent quarter.

The official record: Organon’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Organon's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's net debt / EBITDA?
Organon (OGN) reported net debt / EBITDA of 6× in Q3 2025.
How has Organon's net debt / EBITDA changed year-over-year?
Organon's net debt / EBITDA increased by 7.2% year-over-year, from 5.6× to 6×.
What is the long-term trend for Organon's net debt / EBITDA?
Over 4 years (2020 to 2024), Organon's net debt / EBITDA has grown at a 438.8% compound annual growth rate (CAGR), from 0× to 5.7×.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.